{"id":"https://openalex.org/W2810733600","doi":null,"title":"The R&D Cost of a New Medicine","display_name":"The R&D Cost of a New Medicine","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2810733600","mag":"2810733600"},"language":"en","primary_location":{"id":"mag:2810733600","doi":null,"is_oa":false,"landing_page_url":"https://EconPapers.repec.org/RePEc:ohe:monogr:000135","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"RePEc: Research Papers in Economics","raw_type":null},"volume":null,"type":"preprint","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031172823","display_name":"Jorge Mestre\u2010Ferrandiz","orcid":"https://orcid.org/0000-0003-0529-1321","observed_orcids":["https://orcid.org/0000-0003-0529-1321"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Mestre-Ferrandiz","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0529-1321","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027208547","display_name":"Jon Sussex","orcid":"https://orcid.org/0000-0001-8970-4546","observed_orcids":["https://orcid.org/0000-0001-8970-4546"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jon Sussex","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8970-4546","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5108114814","display_name":"Adrian Towse","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adrian Towse","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":90,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cost-of-capital","display_name":"cost of capital","score":0.5699999928474426},{"id":"https://openalex.org/keywords/out-of-pocket-costs","display_name":"out-of-pocket costs","score":0.8159999847412109},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.7409999966621399},{"id":"https://openalex.org/keywords/drug-development-efficiency","display_name":"drug development efficiency","score":0.5960000157356262},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.368995726108551},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3567855954170227},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.33293601870536804}],"mesh":[],"locations_count":2,"locations":[{"id":"mag:2810733600","doi":null,"is_oa":false,"landing_page_url":"https://EconPapers.repec.org/RePEc:ohe:monogr:000135","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"RePEc: Research Papers in Economics","raw_type":null},{"id":"mag:3141075412","doi":null,"is_oa":false,"landing_page_url":"https://ideas.repec.org/b/ohe/monogr/000135.html","pdf_url":null,"source":{"id":"https://openalex.org/S4306520202","display_name":"Monographs","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Monographs","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/9","score":0.6299999952316284,"display_name":"Industry, innovation and infrastructure"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3209017840","https://openalex.org/W3087161783","https://openalex.org/W4253495290","https://openalex.org/W3204845157","https://openalex.org/W4400112692","https://openalex.org/W2273267066","https://openalex.org/W1516732157","https://openalex.org/W4213042275","https://openalex.org/W3187980261","https://openalex.org/W2121175754"],"abstract_inverted_index":{"The":[0,119],"cost":[1,140],"of":[2,26,33,43,50,56,141],"R&D":[3,129,136],"for":[4,30,108,114],"a":[5,40,156],"successful":[6],"new":[7,83,106],"medicine":[8,84],"has":[9],"been":[10],"an":[11,73],"important":[12],"policy":[13],"issue":[14],"at":[15],"least":[16],"since":[17],"the":[18,44,48,54,57,67,86,94,115,139,159,165],"1960s.":[19],"Cost":[20],"estimates":[21],"matter":[22],"not":[23],"just":[24],"because":[25,37],"intellectual":[27],"curiosity":[28],"or":[29],"industry":[31],"understanding":[32],"its":[34],"performance,":[35],"but":[36],"they":[38],"are":[39,126,148],"key":[41],"aspect":[42],"international":[45],"debate":[46],"about":[47],"reasonableness":[49],"pharmaceutical":[51],"prices":[52],"and":[53,138,154,161],"magnitude":[55],"long-term":[58],"investments":[59],"involved.":[60],"This":[61],"publication":[62],"reviews":[63],"research":[64],"published":[65],"over":[66],"last":[68],"three":[69],"decades,":[70],"which":[71],"shows":[72],"increase":[74],"in":[75,85,93,97],"costs":[76,102,130],"from":[77],"\u00a3125":[78],"million":[79],"($199":[80],"million)":[81],"per":[82],"1970s":[87],"to":[88,151],"\u00a31.2":[89],"billion":[90],"($1.9":[91],"billion)":[92],"2000s":[95],"(both":[96],"2011":[98],"prices).":[99],"An":[100],"OHE":[101],"analysis":[103],"based":[104],"on":[105],"data":[107],"1998-2002":[109],"agrees":[110],"with":[111],"comparable":[112],"analyses":[113],"same":[116],"time":[117],"period.":[118],"study":[120],"explores":[121],"four":[122],"major":[123],"factors":[124],"that":[125],"producing":[127],"higher":[128],"-":[131],"out-of-pocket":[132],"expenses,":[133],"success/failure":[134],"rates,":[135],"times":[137],"capital.":[142],"It":[143],"also":[144],"discusses":[145],"measures":[146],"companies":[147],"taking":[149],"now":[150],"improve":[152],"efficiency":[153],"offers":[155],"glimpse":[157],"into":[158],"promise":[160],"challenges":[162],"presented":[163],"by":[164],"new,":[166],"gene-based":[167],"sciences.":[168]},"counts_by_year":[{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":26},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":5}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2018-07-10T00:00:00"}